Servicing Healthcare Professionals and Companies
Toll Free Phone: 1-866-892-2032
We Accept:
Free Shipping After: $500

CIMZIA® is an injection manufactured by UCB. It is a TNF-α inhibitor, which makes it effective in treating inflammatory pain. Also, this product is a biologic. This means that it is derived from natural sources. Read on for more information on where to buy CIMZIA®, what it is used for, what side effects patients may experience, and more.

Discover More with a Single Click

Our capabilities extend far beyond what is immediately visible. If our current selection doesn't meet your needs, let's delve deeper. Sign up for bespoke consultancy focusing on solutions for your supply challenges.


What Is CIMZIA® Used For?

CIMZIA® is a Tumour Necrosis Factor Alpha (TNF-α) blocker. This injection is used to treat a variety of conditions:

Crohn’s Disease

Crohn’s disease is a condition which involves inflammation of some parts of the digestive system. CIMZIA® is introduced as a treatment option in the cases where the conventional treatments have failed.

Out of all the patients with Crohn’s disease who were treated with CIMZIA® at the clinical trial, 64% started experiencing improvement after six weeks. At 26 weeks, 48% of them reached the state of remission.

Rheumatoid Arthritis

Rheumatoid arthritis is an autoimmune disease that affects the synovial membrane that lines the joints. This causes painful swelling. In rare cases, rheumatoid arthritis causes inflammation in parts of the body other than joints, such as the eyes and lungs.

CIMZIA® can help treat inflammation triggered by rheumatoid arthritis. Typically, patients experience pain relief 24 weeks after they start the treatment. Others may see benefits as quickly as after one to two weeks.

Plaque Psoriasis

Plaque psoriasis, the most common type of psoriasis, appears on the skin in the form of dry, flaky patches. For many patients, CIMZIA® has shown to be effective in relieving the symptoms of plaque psoriasis for nearly a year. They usually start seeing improvements after six weeks of treatment.

Psoriatic Arthritis

CIMZIA®’s clinical trial resulted in six out of ten patients experiencing improvement in symptoms of psoriatic arthritis, such as joint pain and swelling, after twelve weeks. Others saw improvement after one to two weeks. When it comes to skin-related symptoms, for the majority of the patients, the positive effects were visible after six months.

Ankylosing Spondylitis

Ankylosing spondylitis is a form of arthritis which is manifested as lower back pain. When treated with CIMZIA®, patients typically experience pain relief after twelve weeks, while some see improvements within the first week or two.

Non-Radiographic Axial Spondyloarthritis

Swelling of the joints, back pain and stiffness are symptoms of non-radiographic axial spondyloarthritis that may take one year to improve in patients being treated with CIMZIA®. However, for some, it may only take two weeks.

How Does CIMZIA® Work?

CIMZIA® is a TNF-α blocker. TNF-α is a cytokine whose role is to help control inflammation in the human body. It triggers inflammation in cases where there is a threat, such as a pathogen or tumour, in order to fend them off.

Excessive TNF-α levels may cause inflammatory or autoimmune conditions. Therefore, since CIMZIA® inhibits TNF-α, it works well for treating conditions induced by inflammation.

Side Effects

Some patients who undergo treatment with CIMZIA® injections may experience side effects. During the CIMZIA®’s clinical trials, the most common adverse reactions included upper respiratory infections, rash, and urinary tract infections.

In some cases, patients may develop serious infections that can lead to hospitalization or death. Some of the more serious side effects include:

  • Allergic reactions
  • Heart failure
  • Hepatitis B reactivation
  •  Nervous system issues
  • Immune reactions

Thus, it is of utmost importance that the injection be administered by a licensed healthcare provider, and if you are looking to buy CIMZIA® online, make sure that you make your purchases from trusted sources. The injection may also be administered by the patient or someone else, but that person needs to receive proper training from the medical professional.

CIMZIA® vs Competition

HUMIRA® is one of CIMZIA®’s biggest competitors. Both of these Tumour Necrosis Factor (TNF) blockers are created using living cells. The difference is that the active ingredient found in HUMIRA® is adalimumab, while CIMZIA® contains certolizumab pegol.

CIMZIA® and HUMIRA® are quite similar when it comes to their effects. They are both used to treat:

  • Rheumatoid arthritis
  • Crohn’s disease
  • Psoriatic arthritis
  •  Ankylosing spondylitis
  • Plaque psoriasis

CIMZIA® is approved for treating non-radiographic axial spondyloarthritis, while HUMIRA® is not. On the other hand, HUMIRA® can be used to treat certain conditions in children, while CIMZIA® may not be safe for them.

Where Can I Buy CIMZIA®?

You can buy CIMZIA® wholesale from suppliers. You may contact our sales agents who can direct you where to buy this product. It is essential that you make sure you order CIMZIA® from authentic sources that are authorized to sell this product.


CART (0)

No products in the cart.